List of Figures
Figure 1: Number of Products under Development for Optic Neuropathy
Figure 2: Number of Products under Development by Companies, Optic Neuropathy
Figure 3: Number of Products under Development for Glaucoma
Figure 4: Number of Products under Development by Companies, Glaucoma
Figure 5: Number of Products under Development by Universities/Institutes, Glaucoma
Figure 6: Number of Products under Development for Leber’s Hereditary Optic Neuropathy (Leber Optic Atrophy)
Figure 7: Number of Products under Development by Companies, Leber’s Hereditary Optic Neuropathy (Leber Optic Atrophy)
Figure 8: Number of Products under Development for Optic Neuritis
Figure 9: Number of Products under Development by Companies, Optic Neuritis
Figure 10: Number of Products by Top 10 Targets, Optic Neuropathy
Figure 11: Number of Products by Stage and Top 10 Targets, Optic Neuropathy
Figure 12: Number of Products by Top 10 Mechanism of Actions, Optic Neuropathy
Figure 13: Number of Products by Stage and Top 10 Mechanism of Actions, Optic Neuropathy
Figure 14: Number of Products by Routes of Administration, Optic Neuropathy
Figure 15: Number of Products by Stage and Routes of Administration, Optic Neuropathy
Figure 16: Number of Products by Molecule Types, Optic Neuropathy
Figure 17: Number of Products by Stage and Molecule Types, Optic Neuropathy
Figure 18: Number of Products by Top 10 Targets, Glaucoma
Figure 19: Number of Products by Stage and Top 10 Targets, Glaucoma
Figure 20: Number of Products by Top 10 Mechanism of Actions, Glaucoma
Figure 21: Number of Products by Stage and Top 10 Mechanism of Actions, Glaucoma
Figure 22: Number of Products by Routes of Administration, Glaucoma
Figure 23: Number of Products by Stage and Routes of Administration, Glaucoma
Figure 24: Number of Products by Top 10 Molecule Types, Glaucoma
Figure 25: Number of Products by Stage and Top 10 Molecule Types, Glaucoma
Figure 26: Number of Products by Targets, Leber’s Hereditary Optic Neuropathy (Leber Optic Atrophy)
Figure 27: Number of Products by Stage and Targets, Leber’s Hereditary Optic Neuropathy (Leber Optic Atrophy)
Figure 28: Number of Products by Mechanism of Actions, Leber’s Hereditary Optic Neuropathy (Leber Optic Atrophy)
Figure 29: Number of Products by Stage and Mechanism of Actions, Leber’s Hereditary Optic Neuropathy (Leber Optic Atrophy)
Figure 30: Number of Products by Routes of Administration, Leber’s Hereditary Optic Neuropathy (Leber Optic Atrophy)
Figure 31: Number of Products by Stage and Routes of Administration, Leber’s Hereditary Optic Neuropathy (Leber Optic Atrophy)
Figure 32: Number of Products by Molecule Types, Leber’s Hereditary Optic Neuropathy (Leber Optic Atrophy)
Figure 33: Number of Products by Stage and Molecule Types, Leber’s Hereditary Optic Neuropathy (Leber Optic Atrophy)
Figure 34: Number of Products by Targets, Optic Neuritis
Figure 35: Number of Products by Stage and Targets, Optic Neuritis
Figure 36: Number of Products by Mechanism of Actions, Optic Neuritis
Figure 37: Number of Products by Stage and Mechanism of Actions, Optic Neuritis
Figure 38: Number of Products by Routes of Administration, Optic Neuritis
Figure 39: Number of Products by Stage and Routes of Administration, Optic Neuritis
Figure 40: Number of Products by Molecule Types, Optic Neuritis
Figure 41: Number of Products by Stage and Molecule Types, Optic Neuritis